Evidence map›Paper›PMID 38037097›Full record

ArticleJournal of neuroinflammation2023

Single-cell RNA sequencing unveils Lrg1's role in cerebral ischemia‒reperfusion injury by modulating various cells.

Zhaohui Ruan, Guosheng Cao, Yisong Qian, Longsheng Fu, Jinfang Hu, Tiantian Xu, Yaoqi Wu, Yanni Lv

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Insights gained from single-cell sequencing analysis of ischemic stroke.Frontiers in cell and developmental biology · 2026
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Zhaohui Ruan *Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Guosheng Cao *College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China.
Yisong QianSchool of Clinical Medicine, Nanchang University, Nanchang, China.
Longsheng FuDepartment of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Jinfang HuDepartment of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Tiantian XuDepartment of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Yaoqi WuDepartment of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Yanni LvDepartment of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China. yannilv225@ncu.edu.cn.
First Affiliated Hospital of Nanchang University · CNNanchang University · CNHubei University of Chinese Medicine · CN

Funding

National Natural Science Foundation of China 81904028National Natural Science Foundation of China 82100417
6 · The paper itself

Abstract

background and purposeCerebral ischemia‒reperfusion injury causes significant harm to human health and is a major contributor to stroke-related deaths worldwide. Current treatments are limited, and new, more effective prevention and treatment strategies that target multiple cell components are urgently needed. Leucine-rich alpha-2 glycoprotein 1 (Lrg1) appears to be associated with the progression of cerebral ischemia‒reperfusion injury, but the exact mechanism of it is unknown.

methodsWild-type (WT) and Lrg1 knockout (Lrg1

resultsLrg1 expression was increased in various cell types of brain tissue after cerebral ischemia‒reperfusion injury. Lrg1 knockout reduced cerebral edema and infarct size and improved neurological function after cerebral ischemia‒reperfusion injury. Single-cell RNA sequencing analysis of WT and Lrg1

conclusionsOur results has shown that Lrg1 mediates numerous pathological processes involved in cerebral ischemia‒reperfusion injury by altering the functional states of various cell types, thereby rendering it a promising therapeutic target for cerebral ischemia‒reperfusion injury.

Indexed as

Brain IschemiaReperfusion InjuryAnimalsBlood-Brain BarrierBrainGlycoproteinsHumansMiceSequence Analysis, RNAGlycoproteinsLRG1 protein, mouseCerebral ischemia–reperfusion injuryLrg1 knockoutMicroglial cellSingle-cell RNA-seq

Identifiers

PMID38037097
PMCPMC10687904
OpenAlexW4389195510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.